Shares of Moderna have been volatile at the start of 2025 amid a weak growth outlook. Demand for its COVID-19 vaccine has dropped while sales of its new RSV vaccine have been sluggish. An ...

Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25. Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft ...

MLB, Topps and Nike have partnered to recognize baseball's elite performers from last season with custom gold-embellished MLB logos on their jerseys that will then be used to create trading cards.

For a sumptuous sleep experience, you might consider booking a night at the Ritz-Carlton, but what if we told you you don't have to leave your house to enjoy its world-famous Ritz-Carlton hotel ...

Foroohar, a top biotech analyst, has slapped an “underperform” rating on Moderna, the sector’s brightest star in the heady decadelong boom that culminated in the industry’s rally to combat ...

Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever received at the company. The 16.4% increase—at grant value—came ...

A new project, called Block 216, would be his most ambitious ever. It would have five floors of prime office space, a Ritz-Carlton hotel, and 132 Ritz-Carlton condominiums. At a groundbreaking ...